Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
2
×
clinical trials
deals
fda
life sciences
2
×
national blog main
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
amgen
amyotrophic lateral sclerosis (als)
autoimmune disorders
boston
complement system
evolocumab
generalized myasthenia gravis
immune-mediated necrotizing myopathy
inclisiran
national top stories
new york
new york blog main
new york top stories
novartis
pcsk9
pcsk9 inhibitors
ra pharmaceuticals
rare disease drugs
regeneron pharmaceuticals
rna interference
sanofi
the medicines company
ucb
zilucoplan
What
deal
2
×
drug
2
×
medicines
acquire
agreed
alternative
autoimmune
billion
brings
candidate
cash
cholesterol
company
compound
disease
expensive
fda
lead
medco
new
novartis
pharma
pharmaceuticals
poised
potential
ra
ready
stakes
territory
ucb
viewed
wave
world
Language
unset
2
×
Current search:
drug
×
biotech
×
unset
×
" life sciences "
×
" boston top stories "
×
deal
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
